1.Expressions of Fas,FasL,Bcl-2 and Bax proteins in thyroid tissue from patients with Graves′ disease
Jialing WANG ; Yaping ZHAO ; Zhiyong FAN ; Hejun WU ; Wei ZHOU ; Zehong LIU
Chinese Journal of Endocrinology and Metabolism 1985;0(02):-
Objective To investigate the association of the expressions of Fas, FasL, Bcl-2 and Bax in thyroid tissue with the pathogenesis in Graves′ disease (GD). Methods Thyroid tissues from 54 patients with GD and 10 patients with thyroid adenoma (paraadenoma tissue as normal controls) were studied for Fas, FasL, Bcl-2 and Bax expressions in the thyrocytes and lymphocytes by immunohistochemical method. Quantitative analysis was performed by Mias 99 pathological image system. Results (1) The positive granule area, average light density and integrated light density of Fas, FasL, Bcl-2 and Bax in the thyroid tissue from patients with GD were higher than those from normal controls (P
2.Effect and mechanism of liraglutide on proliferation and apoptosis of human pancreatic cancer cells
Rui WEI ; Jin YANG ; Tianpei HONG ; Hejun ZHAO ; Jing KE ; Wenfang HOU ; Ye LIU
Chinese Journal of Endocrinology and Metabolism 2015;(6):530-534
Objective To investigate the effects and mechanism of glucagon-like peptide-1 ( GLP-1 ) receptor agonist liraglutide on the proliferation and apoptosis of human pancreatic cancer cells. Methods The human pancreatic cancer cell line MIA PaCa-2 was incubated for 24 h with liraglutide at various concentrations (10-1 000 nmol/ L), or with 100 nmol/ L liraglutide for various durations (0-72 h). Cell proliferation was determined by Cell Counting Kit-8 (CCK-8) analysis. RT-PCR and Western blot were used to detect the mRNA and protein expression levels of related genes. Results GLP-1 receptor was expressed in the MIA PaCa-2 cells. Liraglutide suppressed cell proliferation, up-regulated the expression levels of pro-apoptotic protein Bax and down-regulated the expression levels of anti-apoptotic protein Bcl2 in human pancreatic cancer cells in a dose- and time-dependent manner. Meanwhile, liraglutide down-regulated the expression levels of insulin receptor (INSR) and insulin-like growth factor-1 receptor (IGF-1R), and the phosphorylation levels of their downstream signaling proteins Erk1 / 2 and Akt, in a dose- and time-dependent way. Conclusion Liraglutide inhibits proliferation and promotes apoptosis of human pancreatic cancer cells; the process may be mediated via suppressing the expression of INSR and IGF-1R and inhibiting activation of the downstream MEK/ Erk1 / 2 and PI3k/ Akt pathways.
3.Clinical analysis of 34 cases with diffuse alveolar hemorrhage in systemic lupus erythematosus
Zichen HUANG ; Hejun WANG ; Cheng ZHAO ; Leting ZHENG ; Jing WEN ; Zhanrui CHEN ; Ling LEI
The Journal of Practical Medicine 2018;34(1):100-102,106
Objective To identify the clinical characteristics and therapeutic effect of systemic lupus erythematosus (SLE) patients with diffuse alveolar hemorrhage (DAH).Methods Clinical characteristcs,diagnosis,treatment and outcome in 34 patients hospitalized in The First Affiliated Hospital of Guangxi Medical University from January 2006 to December 2016 were retrospectively analyzed.Results The incidence of DAH involvement of SLE was about 0.39%.Median age was 19 (interquartile range (IQR) 11.75 ~ 32) years.The duration of SLE before clinical DAH was 6 months (IQR 2 ~ 15.75) months.The main clinical manifestations of DAH were cough,dyspnea and fever.The SLE disease activity index (SLEDAI) score was 19.5 (16 ~ 25)points and anti-dsDNA antibody titer elevated markedly (38.2%).The overall mortality rate was 73.5%,however patients who chose department of rheumatism have lower mortality (52.9%).And treatment of CTX was associated with mortality (OR =0.059,95% CI 0.006 ~ 0.554,P =0.013),as well as steroids and immunosuppressant combination therapy.Conclusions The clinical symptoms of SLE with DAH is often atypical.There is manifestation of cough,fever,dyspnea and etc.Imaging and broncoscopy can assist the diagnosis and its prone to the pulmonary infection and high mortality.Early diagnosis and application of CTX combined with conventional dose of hormone theraphy can in early diagnosis and reduce the mortality.
4.Comparative study of low-keV deep learning reconstructed images and conventional images of gastric cancer based on dual-energy CT
Mengchen YUAN ; Yiyang LIU ; Hejun LIANG ; Lin CHEN ; Shuai ZHAO ; Yaru YOU ; Jianbo GAO
Chinese Journal of Radiology 2024;58(8):836-842
Objective:To assess the quality of low-keV monoenergetic images using deep learning image reconstruction (DLIR) algorithm combined with dual energy CT (DECT) in gastric cancer and to compare them with images from the conventional adaptive statistical iterative reconstruction (ASiR-V) algorithm.Methods:In this cross-sectional study, DECT images of 31 gastric cancer patients in the First Affiliated Hospital of Zhengzhou University were prospectively collected from September 2022 to March 2023. The 55 keV monoenergy images were reconstructed using the DLIR algorithm at low-, medium-, and high-intensity levels (DLIR-L, DLIR-M, and DLIR-H) based on arterial phase and venous phase images, respectively. The 70 keV 40% mixing coefficient (ASiR-V40%) images were reconstructed using the ASiR-V algorithm. In the objective evaluation of images, the signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR) for both lesions and muscle were calculated across four sets of reconstructed images. In the subjective evaluation of images, scores were assigned to the overall image quality, lesion visibility, and diagnostic confidence for each set of reconstructed images. Comparisons of SNR and CNR between the 4 groups were made by One-way repeated-measures ANOVA or Friedman′s test. Comparisons of scores were made by Friedman′s test. The P value of pairwise comparison was adjusted using Bonferroni correction methods. Results:In the objective evaluations, CNR lesion, SNR lesion and SNR muscle were highest on the 55 keV DLIR-H images in the arterial and venous phases, and showed a gradually increasing trend on the 70 keV ASiR-V40%, 55 keV DLIR-L, DLIR-M, DLIR-H images ( P<0.05). In subjective evaluations, compared to the 70 keV ASiR-V40% images, overall image quality scores were numerically higher for the 55 keV DLIR-H ( P>0.05), similar or slightly worse for the 55 keV DLIR-M, and significantly lower for the 55 keV DLIR-L ( P<0.05). The lesion visibility and diagnostic confidence on the 55 keV DLIR reconstruction images were higher in both arterial and venous phases than 70 keV ASiR-V40% images ( P<0.05). Conclusions:Compared to the conventional 70 keV ASiR-V40% images, the 55 keV DLIR-H images had higher lesion contrast and diagnostic confidence with lower image noise. The 55 keV DLIR-M images had comparable overall image quality to 70 keV ASiR-V40% images, but the former had higher lesion contrast and diagnostic confidence. The 55 keV DLIR-L was unable to improve image quality to the level of 70 keV ASiR-V40%.